Meow You can make those judgements in the US market because you have far more data to work with . The EU is more speculation ....different countries provide different coverage . Take the case of Lovaza ( Omacor in Spain ) ...something I'm sure you are familiar with . As I'm sure you are aware ...Spain provided generous coverage for Omacor ..based on the GISSI trial's I believe ...but in recent years withdrew generous coverage and sales of Omacor ...well why tell you . I'm sure you know already . I'm holding out for your $20 a share EU rights ...and in the famous words of JZ ( who you must be familiar with ...and when he said reportedly said it. )...." will not accept a penny less " Kiwi